Suppr超能文献

治疗单个和多个牙周退缩型缺损的根覆盖手术:一项更新的 Cochrane 系统评价。

Root coverage procedures for treating single and multiple recession-type defects: An updated Cochrane systematic review.

机构信息

MSc Dentistry Program, Ibirapuera University, São Paulo, Brazil.

Unit of Basic Oral Investigation (UIBO), School of Dentistry, Universidad El Bosque, Bogota, Colombia.

出版信息

J Periodontol. 2019 Dec;90(12):1399-1422. doi: 10.1002/JPER.19-0079. Epub 2019 Aug 18.

Abstract

BACKGROUND

This updated Cochrane systematic review (SR) evaluated the efficacy of different root coverage (RC) procedures in the treatment of single and multiple gingival recessions (GR).

METHODS

We included randomized controlled trials (RCTs) only of at least 6 months' duration evaluating Miller's Class I or II GR (≥3 mm) treated by means of RC procedures. Five databases were searched up to January 16, 2018. Random effects meta-analyses were conducted thoroughly.

RESULTS

We included 48 RCTs in the SR. The results indicated a greater GR reduction for subepithelial connective tissue grafts (SCTG) + coronally advanced flap (CAF) compared to guided tissue regeneration with resorbable membranes (GTR rm) + CAF (mean difference [MD]: -0.37 mm). There was insufficient evidence of a difference in GR reduction between acellular dermal matrix grafts (ADMG) + CAF and SCTG + CAF or between enamel matrix derivative (EMD) + CAF and SCTG + CAF. Greater gains in the keratinized tissue width (KTW) were found for SCTG + CAF when compared to EMD + CAF (MD: -1.06 mm), and SCTG + CAF when compared to GTR rm + CAF (MD: -1.77 mm). There was insufficient evidence of a difference in KTW gain between ADMG + CAF and SCTG + CAF.

CONCLUSIONS

SCTG, CAF alone or associated with another biomaterial may be used for treating single or multiple GR. There is also some evidence suggesting that ADMG appear as the soft tissue substitute that may provide the most similar outcomes to those achieved by SCTG.

摘要

背景

本项更新的 Cochrane 系统评价(SR)评估了不同的根覆盖(RC)程序在治疗单个和多个牙龈退缩(GR)中的疗效。

方法

我们仅纳入了至少 6 个月的 RC 程序治疗 Miller Ⅰ类或Ⅱ类 GR(≥3mm)的随机对照试验(RCT)。截至 2018 年 1 月 16 日,我们对 5 个数据库进行了检索。我们彻底进行了随机效应荟萃分析。

结果

SR 共纳入了 48 项 RCT。结果表明,与引导组织再生加可吸收膜(GTR rm)+冠向复位瓣(CAF)相比,上皮下结缔组织移植(SCTG)+CAF 可使 GR 减少更多(平均差值[MD]:-0.37mm)。ACDF 与 SCTG+CAF 或 EMD+CAF 与 SCTG+CAF 之间,以及 ADMG+CAF 与 SCTG+CAF 之间,在 GR 减少方面无差异的证据尚不充分。与 EMD+CAF 相比,SCTG+CAF 时角化组织宽度(KTW)增加更多(MD:-1.06mm),与 GTR rm+CAF 相比,SCTG+CAF 时 KTW 增加更多(MD:-1.77mm)。ADMG+CAF 与 SCTG+CAF 之间,KTW 增加方面无差异的证据尚不充分。

结论

SCTG、CAF 单独或与另一种生物材料联合使用,可用于治疗单个或多个 GR。也有一些证据表明,ADMG 可能是软组织替代物,可提供与 SCTG 相似的结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验